Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis
- 1 September 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 15 (9) , 851-860
Abstract
Introduction: Osteomyelitis, a common and debilitating invasive infection of bone, is a frequent complication following orthopedic surgery and causes pathologic destruction of skeletal tissues. Bone destruction during osteomyelitis results in necrotic tissue, which is poorly penetrated by antibiotics and can serve as a nidus for relapsing infection. Osteomyelitis therefore frequently necessitates surgical debridement procedures, which provide a unique opportunity for targeted delivery of antimicrobial and adjunctive therapies. Areas covered: Following surgical debridement, tissue voids require implanted materials to facilitate the healing process. Antibiotic-loaded, non-biodegradable implants have been the standard of care. However, a new generation of biodegradable, osteoconductive materials are being developed. Additionally, in the face of widespread antimicrobial resistance, alternative therapies to traditional antibiotic regimens are being investigated, including bone targeting compounds, antimicrobial surface modifications of orthopedic implants, and anti-virulence strategies. Expert commentary: Recent advances in biodegradable drug delivery scaffolds make this technology an attractive alternative to traditional techniques for orthopedic infection that require secondary operations for removal. Advances in novel treatment methods are expanding the arsenal of viable antimicrobial treatment strategies in the face of widespread drug resistance. Despite a need for large scale clinical investigations, these strategies offer hope for future treatment of this difficult invasive disease.Keywords
This publication has 98 references indexed in Scilit:
- New antibiotics for bad bugs: where are we?Annals of Clinical Microbiology and Antimicrobials, 2013
- The use of gentamicin-coated nails in the tibia: preliminary results of a prospective studyArchives of orthopaedic and trauma surgery, 2011
- Bacterial Colonization of Bone Allografts: Establishment and Effects of AntibioticsClinical Orthopaedics and Related Research, 2010
- d -Amino Acids Trigger Biofilm DisassemblyScience, 2010
- Aryl Rhodanines Specifically Inhibit Staphylococcal and Enterococcal Biofilm FormationAntimicrobial Agents and Chemotherapy, 2009
- A Fatty Acid Messenger Is Responsible for Inducing Dispersion in Microbial BiofilmsJournal of Bacteriology, 2009
- The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infectionBiomaterials, 2008
- Synergistic Activity of Dispersin B and Cefamandole Nafate in Inhibition of Staphylococcal Biofilm Growth on PolyurethanesAntimicrobial Agents and Chemotherapy, 2007
- Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitisInternational Orthopaedics, 2007
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006